Back toACAD
ACAD

Acadia Pharmaceuticals Inc (ACAD) earnings date, market-implied expected move, and options open interest by expiry

earnings room

26.87−1.54%

Next report

fiscal Q3 2026
Nov 4

after close · estimated date

45

days out

Track ACAD

Watchlist prices, news filtered to it, and its next report on your desk.

Market-implied ranges describe what current option prices imply, never a forecast. Prices via Intrinio.

Not investment advice. Varamir is not a brokerage and does not execute orders. Prices via Intrinio; the tape shows ETF proxies. The supply-chain graph is published under CC BY 4.0; licensed market data is not redistributable.